MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients
about
miRNAs Participate in MS Pathological Processes and Its Therapeutic ResponseMicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune ResponseBiomarkers of therapeutic response in multiple sclerosis: current statusPGS: a tool for association study of high-dimensional microRNA expression data with repeated measures.Multiobjective triclustering of time-series transcriptome data reveals key genes of biological processes.Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms.Expression, regulation and function of microRNAs in multiple sclerosisNatalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent.Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.MicroRNAs: The Role in Autoimmune InflammationMeta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis.Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis.The Characterization of GSDMB Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in Multiple Sclerosis.MicroRNAs and multiple sclerosis: from physiopathology toward therapy.Epigenetics of multiple sclerosis: an updated review.miRNA in multiple sclerosis: search for novel biomarkers.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.Circulating Extracellular microRNA in Systemic Autoimmunity.Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.Regulatory role of small nucleolar RNAs in human diseases.Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.MiR-126: a novel route for natalizumab action?Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).Roles of miR‑4463 in H2O2‑induced oxidative stress in human umbilical vein endothelial cells.Editorial on the Special Issue: Regulation by non-coding RNAs.MicroRNA regulation in human CD8+ T cell subsets--cytokine exposure alone drives miR-146a expression.Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease.miR-155 Dysregulation and Therapeutic Intervention in Multiple Sclerosis.miR-145 and miR20a-5p Potentially Mediate Pleiotropic Effects of Interferon-Beta Through Mitogen-Activated Protein Kinase Signaling Pathway in Multiple Sclerosis Patients.Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation.Differentially expressed microRNA in multiple sclerosis: A window into pathogenesis?Expression profiling of peripheral blood miRNA using RNAseq technology in dairy cows with Escherichia coli-induced mastitis
P2860
Q26748774-3AC751D1-F737-45D6-B5F4-F1936463C143Q26798503-B2239E7C-C16A-4B1E-9CD2-8BF55C5731D9Q27012726-68F21964-F16E-46AD-BF03-7372FF74B9C4Q30832314-329BBB5E-7FE4-49C1-A0D1-39072653B694Q30976575-9D110D81-1888-4509-B64B-92971527D014Q31134332-69C8BDBC-D6A0-4B59-9AE0-474D7223360BQ33754662-8E861417-BB49-47E7-925C-BC9645C74795Q34994463-A39DDA07-9371-45D2-BB24-4913683639B9Q35625089-F057A50A-068B-4F2A-853D-77F565C2B1D8Q36088154-EF50BC56-8C48-4680-893C-9A8578B46C96Q36527783-71089235-52C2-4FF6-BAFB-F72C466ACF05Q36655150-C4581B57-289A-4946-BAA0-A1F16A7B45B1Q36815415-59BAEA0B-5231-442D-9D54-681857F61681Q37050779-D7699391-E722-4195-AA0B-EBE92A7B4A78Q37367956-A977DCC4-C1C0-4852-9523-A17A10A77753Q37622730-62789127-3E3A-466C-89C5-EAC59B226F53Q37729175-D04A4809-9817-476C-97E1-A97878783338Q38140046-3BE5A92A-AD6A-4897-8CC9-603F26895030Q38197927-78879F7A-A7C3-41CE-B732-9B183B22D334Q38447020-5A6E64A7-F770-4738-8913-B29279A4C1A4Q38590773-A93FCBCA-9385-48C3-BAFE-2E45C0538815Q38610689-0909B9AD-12D9-4A74-85FB-6764C73F5936Q38648011-4226B750-B9D0-4C60-9ECE-B3E57A997A7DQ38836070-519883B9-846E-4894-82E5-50406AB4E8C2Q38984981-97E0249F-CFC2-4FE9-A2BB-8973BB8540BDQ40402131-F9111F7B-D135-4076-9B1D-0ECF485669FEQ40550308-22F6C258-7372-49DF-A08E-5D0DCF174F3CQ41715953-D3D853E5-D546-4E6D-BB22-1FC07DFC0237Q42233577-3B60BC52-6767-414B-BB77-C831BFE4AA04Q42427048-698B565D-93D4-4168-ABCB-7563F0CD8016Q42546844-5D68DC31-388D-487D-87EA-CA341C4F4FE1Q42836054-D2EF07F5-CFF9-440D-BF9A-1951ECFE3AD2Q42974014-5FC50E84-9BAA-4AF5-8C65-A2370B566B64Q47395782-E9C1547C-3327-41E2-8DFF-432F1E2622B9Q48108346-865550CC-BC2F-457E-B97B-EFC8EFBE1E9DQ51381933-B0AE487B-7A6E-4C55-90FD-F4E5ABBB276EQ55265126-A02584F4-BE19-4205-A08F-A41D7E226B64Q56688688-08CB37C5-0AC1-47DC-9484-700DC27598CCQ58714778-17475C7B-E93A-4954-94E6-CE24D6B6AA26
P2860
MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA expression changes du ...... of multiple sclerosis patients
@en
MicroRNA expression changes du ...... f multiple sclerosis patients.
@nl
type
label
MicroRNA expression changes du ...... of multiple sclerosis patients
@en
MicroRNA expression changes du ...... f multiple sclerosis patients.
@nl
prefLabel
MicroRNA expression changes du ...... of multiple sclerosis patients
@en
MicroRNA expression changes du ...... f multiple sclerosis patients.
@nl
P2093
P2860
P921
P356
P1476
MicroRNA expression changes du ...... of multiple sclerosis patients
@en
P2093
Dirk Koczan
Georg Füllen
Hans-Jürgen Thiesen
Ina Schröder
Kristin Flechtner
Madhan Thamilarasan
Sherry Freiesleben
Uwe Klaus Zettl
P2860
P304
16087-16110
P356
10.3390/IJMS140816087
P407
P577
2013-08-05T00:00:00Z